Anti-aging drug for dogs moves closer to gaining FDA approval
An experimental anti-aging drug aimed at extending the lifespans of large-breed dogs is moving through the FDA process, prompting debate over ethics, regulation, and how much society should invest in companion-animal medicine. Commenters weigh evolutionary explanations for programmed aging, the tradeoffs of selectively breeding dogs, and parallels to emerging human longevity treatments. The thread also branches into practical pet-care topics such as arthritis therapies like Librela/Solensia, diet and hydration for cats, and concerns about dog welfare in urban environments and breed health.
Biology and “programmed” aging
- Some discuss why animals would have hormones that accelerate aging instead of just “wearing out.”
- Proposed explanations: aging pathways are side effects of growth/healing hormones like IGF‑1; high growth hormone is advantageous for large predators but shortens lifespan.
- Natural selection optimizes replication, not individual health; faster turnover can be adaptive in scarce environments.
- Examples like octopus “programmed death” after reproduction are cited as precedent for hormonally triggered aging.
Media source and primary information
- Several dislike Fox News as a source, calling it untrustworthy, but note that for low‑stakes, nonpolitical science news it may be fine.
- Others share the company’s press release and alternate news links.
Anti‑arthritis biologics (Librela/Solensia)
- Many report strong positive experiences with Librela for dogs and Solensia for cats: rapid pain relief, restored mobility, and perceived “extra time” with older pets.
- A few describe more modest improvements, cautioning against calling it a miracle.
- Typical reported costs are around $80–$100/month, varying by country and pet size.
- These are framed as arthritis pain treatments, not life‑extension per se.
Regulation of veterinary drugs
- One side argues FDA resources shouldn’t be “wasted” on pet drugs; market forces and safety‑only rules should suffice.
- Others counter that:
- People spend heavily on pets and need protection from snake oil, especially for life‑extension claims.
- Rigorous trials are essential to measure lifespan effects; without regulation, companies lack incentive to run them.
- FDA oversight also protects the food chain and ecosystems.
- Some doubt that dropping animal regulation would meaningfully speed human drug approvals.
Extending pet lifespans vs accepting death
- Some view canine life‑extension and “transanimalism” as resisting the natural passage of time and grief.
- Others respond that dogs die far too early, and improving longevity is a compassionate, legitimate scientific goal.
- Debate touches on broader human life‑extension; some see indefinite lifespan as inevitable, others as unproven wishful thinking.
Breeds, size, and health
- Multiple commenters advocate for mixed‑breed dogs and cats as generally healthier than inbred purebreds.
- Discussion notes extreme artificial selection in dogs (e.g., brachycephalic breeds, giant breeds) and associated health and lifespan trade‑offs.
- Some question the point of making giant dogs live longer instead of choosing healthier, medium‑sized breeds; others emphasize the unique temperament and family value of giant breeds.
Pit bull safety debate
- One cluster warns strongly against pit bulls and mixes, citing personal experiences and studies showing overrepresentation in severe/fatal attacks.
- Critics argue “pit bull” is a vague category, many statistics are methodologically weak, and socio‑economic factors and training/socialization are more important than genetics alone.
- Some maintain that any large, powerful breed can be dangerous; others insist pit‑type dogs are uniquely risky.
Cat longevity and care tips
- Thread on cat “anti‑aging” focuses on fundamentals rather than drugs: high‑meat diets, avoiding or limiting dry food, ensuring hydration, indoor‑only living, and environmental enrichment.
- Some recommend raw or high‑meat wet food for issues like IBD and urinary health, reporting substantial improvements.
- There is debate over dry food’s dental benefits; several argue it’s overstated and prefer tooth‑brushing or chewy/raw foods.
- Indoor vs outdoor and single vs multiple cats are discussed:
- Indoor life is defended as safer and low‑stress if owners provide play, toys, and window views.
- Others worry about restricted “freedom” and suggest multiple indoor cats where owners are often away.
Big dogs in urban environments
- One commenter is disturbed by large, high‑energy dogs kept in small city apartments, calling it near‑torture if they lack space and proper exercise.
- Others note that well‑exercised city dogs can be fine, but acknowledge it’s harder to meet their needs in dense urban settings.
Company participation and miscellany
- The startup’s founder briefly appears in the thread, describing the FDA milestone as a significant step for both dogs and lifespan‑extension pharma.
- A few note the irony/humor of Fox covering a dog‑related story.